Over the course of the forecast period, the near-patient molecular solutions market is anticipated to grow at an impressive CAGR of 8%. The market is expected to grow from US$ 3.5 billion in 2023 to US$ 7.56 billion by 2033, according to FMI. The increasing prevalence of diseases such as diabetes and cardiac diseases is …